Lacteeze Tablets - Extra Strength 4500 Unit Tablet is a Health Canada–registered human drug (DIN 02239638) held by Gelda Scientific And Industrial Development Corporation, containing Lactase. Health Canada lists its status as Cancelled Pre Market (status date 05 Sep 2017). Nexara Health has matched 5 registrations of Lactase across 3 other regulated markets.
Health Canada registration
| DIN | 02239638 |
|---|---|
| Brand name | Lacteeze Tablets - Extra Strength |
| Active ingredient | Lactase |
| Strength | 4500 Unit |
| Dosage form | Tablet |
| Route | Oral |
| Company | Gelda Scientific And Industrial Development Corporation |
| Status | Cancelled Pre Market — 05 Sep 2017 |
| Class | Human |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Lactase registered in other markets
5 registrations of the same molecule in 3 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Jordan | Advancis® Colibaby. | Labialfarma – Laborat?rio de Produtos Farmacêutidos e Nutracêuticos S.A. | 25 ML/50 ML | Oral solution | NEW APPLICATION | JFDA drug registrations |
| Malaysia | Lactzym Lactase 45mg tablets | Quanstar Biotech Sdn Bhd | Health Supplement | PRODUCT APPROVED | NPRA | |
| United Arab Emirates | Delictase | LECIFARMA-ESPECIALIDADES FARMACEUTICAS E PRODUTOS GALENICOS, LDA., Portugal, Loures | 30 mg | Capsule | Active | EDE |
| United Arab Emirates | Delictase Oral Drops | LECIFARMA-ESPECIALIDADES FARMACEUTICAS E PRODUTOS GALENICOS, LDA., Portugal, Loures | 9.75 ml/15ml | Drops | Active | EDE |
| United Arab Emirates | Lactacol® Capsules | salix srl, Italy, Monte di malo | 30mg/Capsule | Capsule | Active | EDE |
See every manufacturer of Lactase worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Lacteeze Tablets - Extra Strength (DIN 02239638) marketed in Canada?
No. Health Canada lists DIN 02239638 as Cancelled Pre Market as of 05 Sep 2017.
Who holds the Canadian licence for this product?
Gelda Scientific And Industrial Development Corporation is the company of record in the Health Canada Drug Product Database.
Is Lactase registered outside Canada?
Yes — Nexara Health has matched 5 registrations in 3 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02239638, status date 2017-09-05; national medicine registries: EDE, JFDA drug registrations, NPRA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02239638, status date 2017-09-05; national medicine registries: EDE, JFDA drug registrations, NPRA.
Health Canada Drug Product Database (DPD), DIN 02239638, status date 2017-09-05; national medicine registries: EDE, JFDA drug registrations, NPRA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.